Skip to content
drillr.ai
Sign up

BIVI

BioVie Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.00
−1.48%
Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue—————
Cost of Revenue178.3K—229.4K——
Gross Profit(178.3K)—(229.4K)——
Operating Expenses
R&D Expense14.0M14.0M9.3M23.1M33.3M
SG&A Expense8.5M8.5M8.6M—11.6M
General & Admin Expense12.7M8.5M———
Selling & Marketing Expense(4.1M)————
Other Expenses6.3K178.3K—9.1M229.4K
Total Operating Expenses22.5M22.7M17.8M32.2M45.1M
Cost and Expenses22.7M22.7M18.1M32.2M45.1M
Operating Income (EBIT)(22.7M)(22.7M)(18.1M)(32.2M)(45.1M)
Non-Operating
Interest Income596.8K596.8K853.0K1.1M562.3K
Interest Expense17.9K17.9K332.7K2.9M4.3M
Net Interest Income578.9K578.9K520.3K(1.8M)(3.7M)
Other Non-Op Income/Expense578.9K578.9K524.1K59.1K(5.2M)
Non-Operating Income (excl Interest)(475.3K)(596.8K)(856.8K)(3.0M)875.2K
EBT (Pre-Tax Income)(22.1M)(22.1M)(17.5M)(32.1M)(50.3M)
Income Tax Expense—————
Bottom Line
Net Income(22.1M)(22.1M)(17.5M)(32.1M)(50.3M)
Earnings from Cont. Ops(22.1M)(22.1M)(17.5M)(32.1M)(50.3M)
Earnings from Discont. Ops—————
Bottom Line Net Income(22.1M)(22.1M)(17.9M)(33.0M)(50.3M)
Per Share
Basic EPS($3.20)($3.05)($12.12)($73.05)($154.70)
Diluted EPS($3.20)($3.05)($12.12)($73.05)($154.70)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding7.5M7.2M1.5M451853324834
Diluted Shares Outstanding7.5M7.2M1.5M451853324834
Profitability Metrics
EBITDA(22.0M)(21.9M)(17.0M)(29.0M)(45.7M)
D&A178.3K178.3K229.4K229.4K229.4K
EBIT(22.2M)(22.1M)(17.2M)(29.2M)(46.0M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026